Purple Biotech Ltd.

Regulatory Filings • Jan 8, 2020

Press Release: Kitov Pharma Granted Additional 180-day Extension by Nasdaq to Comply with Bid Price Rule false

����� ����� ��"�	2 380
KITOV PHARMA LTD
Corporation no: 520031238	10994
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	08/01/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-003606	Time of broadcast: 13:52 13:51:44

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress Release: Kitov Pharma Granted Additional 180-day Extension by Nasdaq to Comply with Bid Price Rule

pressrelease010820b_kitovpharmaDRAFT1_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 31/12/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office
Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: abz@abz-law.com 1
Israel